Thursday 22nd December 2022 |
Text too small? |
Cannasouth Limited (NZX: CBD ) is pleased to announce the appointment of Pierre Booysen as Chief Compliance Officer for the group, commencing early February 2023.
Mr Booysen will provide strategic leadership for all quality and regulatory functions across the group to support the business goals. He brings with him extensive knowledge and experience in the medicinal cannabis industry and the New Zealand regulatory system, having worked as a Senior Advisor (GMP audit) with Medsafe and Team Leader with Medicinal Cannabis Agency. He is a pharmacist by profession, with a background in various production, regulatory affairs and quality roles in the pharmaceutical industry. He holds a Bachelor of Pharmacy and Master of Science in Pharmaceutical Chemistry.
CEO Mark Lucas says “Cannasouth has an existing team of high-caliber quality and regulatory professionals who have successfully obtained commercial activity licences and product assessments under the Medicinal Cannabis Scheme and are prepared for a GMP audit of our cultivation facility to achieve GMP certification.
“This new Chief Compliance Officer role is key to leading the quality and regulatory team to find the fastest pathways to market and supporting the product innovation process.”
Booysen says “I was ready to take the next step in my career by returning to industry, as well as relocating our young family before they enter the school system. Cannasouth has always presented itself as a leader in its field with strong values and integrity. I’m pleased to join a company whose values algin with my own, where I can continue to contribute to making novel medicinal cannabis products available to more New Zealanders.”
Booysen’s first priorities will be leading the verification of flower products for local and export markets and mapping the regulatory approach for the company’s next generation finished product formulations and other key projects. He will also be responsible for integrating the quality and regulatory teams at Cannasouth and Eqalis if the proposed merger, announced on 19 December 2022, is approved by shareholders.
-ENDS-
No comments yet
December 31st Morning Report
December 30th Morning Report
December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report